Justifications or motivations for conducting a drug discontinuation trial from the investigators point of view could be grouped in seven categories (Table 5): the most frequently given reason for conducting a DDT were concerns for drug toxicity [e.g., rheumatoid arthritis treatment with TNF inhibitors (49%) [13]. This evidence concerns the gene TNF and rheumatoid arthritis.